Wuhan Wuyao Pharmaceutical Co., Ltd., a holding subsidiary of Grand Pharmaceutical (China) Co., Ltd., Is a hi-tech enterprise engaged in API productions and sales. The company mainly produces Analgin, Metronidazole, Enoxacin, and Pirenoxine sodium APIs and their Intermediates. It has more than 40 products, with an annual product...
Wuhan Wuyao Pharmaceutical Co., Ltd., a holding subsidiary of Grand Pharmaceutical (China) Co., Ltd., Is a hi-tech enterprise engaged in API productions and sales. The company mainly produces Analgin, Metronidazole, Enoxacin, and Pirenoxine sodium APIs and their Intermediates. It has more than 40 products, with an annual production capacity of over 4,000 tons. Its products, Hydrochloric acid tirofiban, and enoxacin, are national Second-class drugs. What's more, sodium pirenoxine and Adrenaline series are the company's exclusive products in China.
Wuhan Wuyao Pharmaceutical Co., Ltd., a holding subsidiary of Grand Pharmaceutical (China) Co., Ltd., Is a hi-tech enterprise engaged in API productions and sales. The company mainly produces Analgin, Metronidazole, Enoxacin, and Pirenoxine sodium APIs and their Intermediates. It has more than 40 products, with an annual product...
Wuhan Wuyao Pharmaceutical Co., Ltd., a holding subsidiary of Grand Pharmaceutical (China) Co., Ltd., Is a hi-tech enterprise engaged in API productions and sales. The company mainly produces Analgin, Metronidazole, Enoxacin, and Pirenoxine sodium APIs and their Intermediates. It has more than 40 products, with an annual production capacity of over 4,000 tons. Its products, Hydrochloric acid tirofiban, and enoxacin, are national Second-class drugs. What's more, sodium pirenoxine and Adrenaline series are the company's exclusive products in China.